Project: The LEAP (Longitudinal European Autism Project) is an accelerated longitudinal study that enrolls 400 patients with autism and 250 typically developing controls diverse in age (6-30 years) and ability level at 7 sites in Europe. The study is part of the EU-AIMS programme (www.eu-aims.eu) that is sponsored by the Innovative Medicines Initiative Joint Undertaking under grant agreement number 115300 (EU-AIMS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007 - 2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution. The data include structural MRI, resting-state MRI, diffusion-weighted MRI, bold-response to tasks (social /non-social reward anticipation, theory of mind, and executive functioning), social and non-social cognition, EEG, biochemistry and DNA. The overall aim is to identify the neural, neurocognitive, genetic, and biomarker mechanisms underlying autism and parsen heterogeneous autism into biologically more homogenous subgroups.
Tasks: analyze existing resting-state MRI and/or DTI data, and publish in high-impact peer-reviewed journals.
Requirements
A completed PhD in neuroscience, psychology, neurobiology or medicine. Extensive experience in analyzing one of more of the following type of data: MRI data (structural MRI and/or resting-state MRI and/or diffusion-weighted MRI, and/or fMRI). Further, you should have an interest in neuropsychiatric disorders as autism. Finally, you have shown to have excellent and efficient writing skills and be able to publish in high-impact journals.
Conditions of employment
Scale 10: max. € 56801 gross income per year at full employment (incl. vacation bonus and end of year payments)
Contract type: Temporary, 2 years
Further details:
http://www.academictransfer.com